IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

API business of Dr. Reddy’s reports fall in sales

8:25 AM MST | November 4, 2013 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 19% fall in sales in the company’s fiscal second quarter, ended 30 September, compared with the year-ago quarter, to 6.4 billion Indian rupees ($103 million), because of fewer launch molecules to customers during the quarter, Dr. Reddy’s says. Earnings figures for the PSAI business have not been disclosed. During the quarter, eight drug master files (DMF) were filed globally, including one in the United States, Dr...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa